Skip to content

FBRX - Forte Biosciences, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchF

Forte Biosciences Inc

FBRX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

F

FBRXForte Biosciences Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $77.20
52-wk low: $10.11
Prev close: $42.45
Mkt cap: $1.63B
Beta: 2.65
P/B: 8.9x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$117.0M

AL
Alger
Q2 2026 13F
$30.6M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 10.2% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.6B

Valuation

P/B8.88

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: FBRX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.63B
Beta: 2.65

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-62.3%

$13.9M

position

P7

Point72

Steven Cohen · Q4 2025 13F

$13.3M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for FBRX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.97+10.2%

-$1.08 expected

Next report

What the street expects next

EPS expected

-$0.78

-$0.78 to -$0.78

Revenue expected

$0.00

2 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

+0.22

Change in 30 days

-62.3%

ROA-37.8%

Growth

Beta2.65